Search

Astellas Pharma Inc.
  • Top MenuAbout
    Corporate Information
    Europe is a global centre of excellence in healthcare and Astellas is committed to supporting Europe, the Middle East and Africa (EMEA)…
    Read More
    • Philosophy
    • Vision & Strategy
    • Group Code of Conduct
    • Corporate Information
    • Policies & Position Statements
    • Medical Education
      • Support for Medical Education
      • Congress: Grants to HCOs
  • Top MenuTherapy areas
    • ADVAGRAF™
    • BETMIGA ™
    • EVRENZO™
    • MYCAMINE™
    • PADCEV™
    • PROGRAFT™
    • VESICARE™
    • VESOMNI™
    • XOSPATA™
    • XTANDI™
  • Top MenuProducts
  • Top MenuInnovation
    Clinical Trials
    Astellas has established a website to disclose information obtained from Astellas-sponsored clinical trials…
    Read More
    • R & D
      • Clinical Trials
      • Approach
      • Ethics & Principles
    • Investigator Sponsored Research
  • Top MenuSustainability
    Access to Health
    Advances continue to be made in technology and medicine that address unmet medical needs. However, there still remain barriers for many people…
    Read More
    • CSR-Based Management
      • ISO26000
      • Materiality
    • CSR Activities in Five Fields
      • Society
      • Environment
      • Employees
      • Ethics & Compliance
    • Access to Health
      • ACTION ON FISTULA™
    • Transparency
    • Modern Slavery Act
    • Global Sustainability Policy
  • Top MenuNews
    Media Contacts
    The Astellas EMEA Corporate Communications team will respond to calls and emails from journalists…
    Read More
    • News
    • Media Contacts
    • Social Media Code of Conduct

Common header menu

  • CAREERS
  • CONTACT US
  • WORLDWIDE
  • NETHERLANDS
  • WORLDWIDE - NETHERLANDS
  1. Home
  2. Site Map

Site Map

Main navigation

  • About
    • Philosophy
    • Vision & Strategy
    • Group Code of Conduct
    • Corporate Information
    • Policies & Position Statements
    • Medical Education
      • Support for Medical Education
      • Congress: Grants to HCOs
  • Therapy areas
    • ADVAGRAF™
    • BETMIGA ™
    • EVRENZO™
    • MYCAMINE™
    • PADCEV™
    • PROGRAFT™
    • VESICARE™
    • VESOMNI™
    • XOSPATA™
    • XTANDI™
  • Products
  • Innovation
    • R & D
      • Clinical Trials
      • Approach
      • Ethics & Principles
    • Investigator Sponsored Research
  • Sustainability
    • CSR-Based Management
      • ISO26000
      • Materiality
    • CSR Activities in Five Fields
      • Society
      • Environment
      • Employees
      • Ethics & Compliance
    • Access to Health
      • ACTION ON FISTULA™
    • Transparency
    • Modern Slavery Act
    • Global Sustainability Policy
  • News
    • News
    • Media Contacts
    • Social Media Code of Conduct

Home menu

  • Header / Footer
    • Header
      • Worldwide
      • Careers
      • Contact Us
    • Footer
      • Site map
      • Privacy Policy
        • HCP Privacy Notice
        • Privacy Notice PV MedInfo
      • Terms of use
      • Contact Us
      • Modern Slavery Act
      • Cookie beleid
LogoSolgan

Follow us on social media

linkedin_icon twitter_icon

Bottom footer menu

  • SITE MAP
  • PRIVACY STATEMENT
  • TERMS OF USE
  • CONTACT US
  • COOKIE BELEID
  • MODERN SLAVERY ACT
© 2020-2022 Astellas Pharma B.V.

Update de cookievoorkeur